Cadence Pharmaceuticals Accounts Receivable:
8.908M for March 31, 2013Cadence Pharmaceuticals Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 8.908M |
| Dec. 31, 2012 | 6.152M |
| Sept. 30, 2012 | 6.848M |
| June 30, 2012 | 4.968M |
| March 31, 2012 | 3.196M |
| Dec. 31, 2011 | 2.208M |
| Sept. 30, 2011 | 1.89M |
| June 30, 2011 | 1.136M |
| March 31, 2011 | 0.818M |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
CADX Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Dendreon | 38.88M |
| Array BioPharma | |
| NuPathe |
CADX Accounts Receivable Rankings
| Overall |
64th percentile 2707 of 7593 |
| Sector |
62nd percentile 245 of 650 in Healthcare |
| Industry |
82nd percentile 42 of 237 in Biotechnology |
CADX Accounts Receivable Range, Past 5 Years
| Minimum | 0.8180M | Mar 2011 |
| Maximum | 8.908M | Mar 2013 |
| Average | 4.014M |
